Medicinova

Medicinova

MNOV· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -37.6% in FY2025

Yuichi Iwaki, M.D., Ph.D. is the CEO of Medicinova and was paid $1.7M in FY2025 (Dec), up 23%.

Pay$100 in the stock at the end of FY21 → $49
CEO pay is from each Medicinova proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Yuichi Iwaki, M.D., Ph.D.FY2025
  2. 2Kazuko Matsuda, M.D., Ph.D., MPHFY2025
  3. 3David H. Crean, Ph.D.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Medicinova paid its 3 named executives $3.2M in total in FY2025 (Dec). CEO Yuichi Iwaki, M.D., Ph.D. was paid $1.7M of that.

Name
Yuichi Iwaki, M.D., Ph.D.President and Chief Executive Officer
Kazuko Matsuda, M.D., Ph.D., MPHSenior Vice President, Chief Medical Officer
David H. Crean, Ph.D.Chief Business OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Medicinova. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 29, 2026FY2025
Annual report10-KMar 10, 2026FY2025
Proxy statementDEF 14AApr 28, 2025FY2024
Annual report10-KFeb 19, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KFeb 15, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data